To own Shibuya, you need to believe the packaging plant and mechatronics franchises can keep turning steady demand for aseptic, pharma, semiconductor and agri systems into durable earnings, even with modest forecast profit growth of 9.6% a year and revenue growth of 6.5% a year. The recent US$48.6 million Delaware judgment is a real cash hit, but it is tied to expired patents, so it does not touch the future sale, use or maintenance of Shibuya’s aseptic filling systems. These systems still sit at the center of the story on execution, order flow and pricing.
In the short term, the ruling adds legal and funding noise to a business that already runs capital intensive equipment lines and uses higher risk borrowing instead of customer deposits. You are weighing that against a company trading on a 15.7x P/E, viewed as good value versus peers at 19.5x, yet expensive against an estimated fair P/E of 14.5x, with high quality earnings but a dividend not well covered by free cash flow and a share price that has moved sharply, including a 40.1% gain over 90 days.
Even so, there is a less obvious pressure point around Shibuya that only really shows up when you look at ...
There's only one way to know the right time to buy, sell or hold Shibuya. Head to Simply Wall St's company report for the latest analysis of Shibuya's Fair Value.
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If this Shibuya story has sharpened your thinking on risk, value and balance sheets, it can help to contrast it with other businesses that score well on different dimensions using the Simply Wall St Screener.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com